In the News | Friends of Cancer Research

You are here

In the News

August 9, 2018
August 9, 2018 - WASHINGTON, D.C. – The American Society of Clinical Oncology, Inc. (ASCO®) and Friends of Cancer Research (Friends) have submitted to the Food and Drug Administration (FDA)... Read more
August 9, 2018
Following years of debate on the issue, FDA is floating a legislative proposal that would cement the agency's authority to regulate high-risk clinical laboratory diagnostics – including laboratory-... Read more
August 9, 2018
ASCO and Friends of Cancer Research (Friends) have submitted recommended language to the U.S. Food and Drug Administration (FDA) for five guidance documents on ways to broaden eligibility criteria... Read more
August 9, 2018
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research have drafted five US Food and Drug Administration (FDA) guidance documents focusing on cancer clinical trial... Read more
August 9, 2018
Representatives of the device industry praised FDA for expanding on concepts included in a diagnostic test oversight bill floating on Capitol Hill, such as creating efficient, predictable pathways to... Read more
August 9, 2018
Groups ask FDA to issue five guidance documents to increase clinical trial eligibility for cancer patients Trials could open to patients with HIV, spread of brain cancer, teenagers   New cancer... Read more
August 9, 2018
The American Society of Clinical Oncology and Friends of Cancer Research have submitted recommended language to the Food and Drug Administration for ways to expand eligibility criteria for cancer... Read more
August 5, 2018
Executive Summary CDER Director Woodcock says for regulatory purposes, using real-world data likely will remain a case-by-case decision.   The US FDA does not appear ready to add indications to drug... Read more
August 1, 2018
Health-care legislation may take a back seat in Congress as Trump’s pick for the Supreme Court and must-pass spending bills will dominate the debate on Capitol Hill.   The House has already left for... Read more
July 31, 2018
A new study this month has added to the so-far scant data available on the ability of Guardant Health's Guardant360 assay to predict responsiveness to immunotherapy using a blood-based signal to... Read more

Pages